We analyzed the DNA sequence of the cDNA encoding the NH2 terminal region of ft spectrin from members of a kindred with autosomal dominant hereditary spherocytosis associated with defective protein 4.1 binding. We found a point mutation at codon 202 within the 272 amino acid NH2-terminal region of 13 spectrin. TGG was changed to CGG, resulting in the replacement of tryptophan by arginine. The base change eliminates a normally occurring PvuII restriction site and creates a new MspI site. This finding enabled rapid detection or exclusion of the mutation at the DNA level among the family members, including one member for whom this analysis was performed prenatally. The mutation was found only in the affected family members and occurred as a de novo mutation in the proband. It has not been found in 20 other kindreds. The recombinant peptide derived from the normal cDNA retains the capacity to sediment with protein 4.1 and F-actin. The mutant peptide spontaneously degrades. This variant represents both the first point mutation and the first,8 spectrin mutation demonstrated in autosomal dominant hereditary spherocytosis. Furthermore, the mutation is located within a conserved sequence among spectrinlike proteins and may define an amino acid critical for protein 4.1 binding activity. (J. Clin. Invest. 1993. 92:612-616.) 
Introduction
Hereditary spherocytosis (HS)' is a clinically and genetically heterogeneous disorder of the red blood cell characterized by increased osmotic fragility and spheroidal shape. There is a classical, autosomal dominant type and a more severe, recessively inherited form (for review, see reference 1) . The bio-chemical defects in these disorders are related to abnormalities in the red blood cell membrane proteins. Deficiency of the erythrocyte membrane skeleton protein, spectrin, has been demonstrated in patients with recessive HS (2) and a majority ofpatients with autosomal dominant HS (3) , and the degree of deficiency appears to correlate with clinical severity (4) .
There is asymmetry in the relative synthetic rates ofa and 1 spectrin, in that the synthesis of a spectrin is threefold in excess of 1 spectrin synthesis in murine, rat, and human erythroblasts (5) (6) (7) . Spectrin assembly on the membrane appears to be rate limited by the ,B chain. Therefore one could predict that defects in 3 spectrin would be manifest in the heterozygous state and result in dominantly inherited conditions. In contrast, defects in a spectrin may not be manifest until the homozygous state is reached, since the a chains are synthesized in excess to the 1.
Three kindreds with autosomal dominant HS in which the spectrin is defective in its ability to bind protein 4.1 (8, 9) have been previously described. In one of the kindreds, previous studies demonstrated that approximately 40% of the spectrin was unable to bind protein 4.1 (9) and that there was abnormal chymotryptic digestion of the isolated f spectrin in individuals from this kindred (10) . There was also spectrin deficiency to 80% of the normal quantity (10) , a level which is comparable with that of the autosomal dominant type of HS. The one unusual feature noted in this kindred was prominent acanthocytosis, even before splenectomy, among the affected individuals (9, 10) .
By electron microscopy, other investigators ( 11 ) had localized the protein 4.1 binding site to the end ofthe spectrin dimer opposite the self-association site, although the specific chain could not be identified. In addition, our prior investigation using photoaffinity, radiolabel-transfer cross-linking demonstrated that the binding site for protein 4 Allele-specific oligomer hybridization. There was one nucleotide substitution identified in only 2 ofthe 13 subclones. In order to exclude this as a polymorphism linked to the mutation or the mutation itself, allele-specific oligomer hybridization was performed as described ( 17) and modified ( 18 ) . The duplicate slot blots ofthe PCR amplified genomic DNA samples were each hybridized with one of the 32P-labeled oligomers, 5 
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represents the ( spectrin ATG codon 202 protein and the second F 1.3kb 1line represents the cDNA for ( spectrin. The NH2-terminal region consists of 272 amino acids (23), after which follow the spectrin repeats. The arrows labeled PI and P2 indicate the position of the primers used for PCR amplification of this region of cDNA. (21 ) . The amount of peptide in the pellets was quantified by elution of the band with 25% pyridine. The A605 of the eluted dye samples was compared with a standard curve constructed from the A605 values for eluted bands from gels run on known microgram quantities of the same protein.
Case report. The clinical course and hematological features of the affected members ofthis kindred have been previously reported (9) . In brief, the proband and two of her children are affected with moderate hemolytic anemia and increased osmotic fragility of erythrocytes. The affected individuals all required splenectomy in childhood, the two daughters of the proband were severely jaundiced at birth, and one underwent exchange transfusion. The father (I-2) ofthe proband (11-2) had previously been reported as an affected individual as a result of a one-point assay of spectrin-protein 4.1 binding at a single concentration (9) . In fact, however, he has less than 10% spherocytes on peripheral smear, a normal hemoglobin, and normal incubated osmotic fragility test, and is thus unaffected by spherocytosis. Nonpaternity was excluded by RFLP analysis (I. G. Laboratories, Inc., Framingham, MA). The probability of paternity was 0.99887 relative to a random man in the North American Caucasian population. The other members of the kindred are clinically unaffected.
Results
Our previous studies (10) of this kindred by proteolytic digestion of the individual spectrin chains had suggested a defect in ( spectrin. We now attempted confirmation of linkage of the ( Spectrin Mutation in Hereditary Spherocytosis 613 defect to A spectrin by RFLP analysis using the HindIII polymorphism at the 3' end ofthe f3 spectrin gene ( 13) . Such analysis did not exclude linkage of the defect in this kindred to (3 spectrin, but because of the small number of family members, the result was not statistically significant (data not shown).
We had also previously shown that the binding site for protein 4.1 was located within the NH2-terminal region of (3 spectrin before the beginning of the spectrin repeat structure ( 12) . We therefore decided to amplify this region of the :3 spectrin cDNA. RNA isolated from peripheral blood reticulocytes of the affected proband was examined by nucleotide sequencing after reverse transcription, PCR, and subcloning. Sequencing of 13 subclones revealed a single base substitution in codon 202 resulting in a change from TGG to CGG in 7 ofthe clones (Fig.  2) . This substitution causes an amino acid replacement of tryptophan by arginine. The mutation abolishes a PvuII restriction site (CAGCTG to CAGCCG) and creates a new MspI site (CTGG to CCGG). These changes enabled subsequent rapid detection in affected and unaffected family members by restriction analysis of PCR amplified genomic DNA. The occurrence ofthe mutation in about halfofthe sublones analyzed is consistent with the heterozygous status of the proband.
The only other nucleotide change found in more than one subclone was a change from TGC to CGC at codon 87, identified in 2 of the 13 subclones. However, allele-specific oligomer hybridization revealed that this change was not present in the affected individuals' genomic DNA (data not shown). Thus, this change was attributed to an error of the Taq polymerase used for PCR.
Restriction enzyme digestion with PvuII ( Fig. 3 ) ofa 1. 1-kb fragment of genomic DNA produced by PCR amplification normally yields products of 500 and 350 bp. In the three affected individuals, an uncleaved product of 850 bp is also generated (Fig. 3) , indicating the presence of the mutation. The affected individuals demonstrated both patterns because they are heterozygous for the mutation, consistent with the dominant nature of the disorder. Neither of the grandparents have the uncleaved product, suggesting that the mutation had occurred spontaneously in the proband and was transmitted to two of her four children. This uncleaved product was also not observed in the unaffected family members, an unrelated control without hemolytic anemia, and one member from each of the other two known HS kindreds (8) with a defect in the binding ofprotein 4.1 by spectrin (Fig. 3) . In addition, no such product was observed in family members from 15 other unrelated kindreds with autosomal dominant HS or 5 unrelated kindreds with nondominant HS (data not shown).
The mutation could be confirmed by restriction enzyme digestion of PCR amplified genomic DNA with MspI. MspI digestion of the same 1. 1-kb fragment (Fig. 4) normally duces products of 650 and 400 bp. Because the mutation creates a new MspI site, an additional product of 600 bp is observed in the three affected family members and not in unaffected individuals. Moreover, the restriction digestion with PvuII was employed to analyze genomic DNA from cultured amniocytes obtained during the proband's fourth pregnancy. The pattern was that of the unaffected individuals, with 500 and 350 bp fragments ( Fig. 3; III-4 ). This analysis represents the first reported prenatal exclusion of HS.
To demonstrate the consequence of this mutation on protein function, we ligated fragments of this region of ( spectrin cDNA into pGEX plasmids. The 64-kD recombinant normal and mutant peptides were produced in E. coli following induction with IPTG. However, after glutathione agarose affinity chromatography, there was rapid degradation of the mutant recombinant peptide to a 32-kD polypeptide (Fig. 5) , which contained GST by immunoblotting studies (data not shown). Presumably, because the molecular weight slightly exceeds that ofGST alone (28 kD), a small fragment ofthe mutant spectrin peptide is likely preserved, attached to the GST.
The purified normal peptide sedimented with F-actin and protein 4.1 (Fig. 5, lane 2 ). There were increasing amounts of peptide sedimented with increasing peptide concentration, although saturation was not quite achieved, probably due to insufficient concentration of the peptide (data not shown). The nonspecific sedimentation of the peptide alone was minimal, in fact, undetectable at the lower concentrations ( 1-4 ,g pep- superfamily as well. The binding site for actin was preserved within an erythroid (3 spectrin peptide consisting of amino acids 47 to 186 (25) , or an even smaller 27 amino acid peptide highly conserved among a actinin, actin binding proteins, (3 spectrin, dystrophin, and fimbrin (26) .
The binding site for erythrocyte protein 4.1 has also been localized to this NH2-terminal region of (3 spectrin ( 12) , although because of the 16-A length of the cross-linker and the nature ofthe proteolytic techniques, the binding site could only be positioned somewhere within the entire 33 kD NH2-terminal domain. The kindred described in this report has a functional defect in roughly half of the spectrin dimers, which lack the capacity to bind protein 4.1 (9) . A single point mutation was found in codon 202 of ( spectrin cDNA, which at the Msp protein level causes a change from the aromatic amino acid, tryptophan, to the positively charged amino acid, arginine. The location of this mutation is within a highly conserved region among members of the spectrin gene superfamily (Fig. 6) . Overall, there is about 50% protein sequence homology among the spectrinlike proteins in the entire NH2-terminal region. Yet in the particular location ofthis mutation, there is even greater conservation of the sequence. Normal Mutant under investigation. Moreover, protein 4.1 is found in numerous nonerythroid tissues, but its function and interactions with other cytoskeletal or membrane proteins are as of yet unknown. Bacterial expression in the pGEX plasmid system of the mutant cDNA encoding the NH2-terminal region of 1 spectrin resulted in an unstable, proteolytically degraded polypeptide. However, the normal recombinant peptide had preserved binding capacity for actin and protein 4.1. One cannot predict whether the mutant protein would be unstable in vivo on the basis of its instability in the bacterial expression system. However, it was found previously that the HS spectrin was more sensitive to oxidation ( 10) . It is also interesting that there was a lower proportion of mutant spectrin isolated by protein 4.1 affinity chromatography (9) than would be predicted in a heterozygous individual (40 vs. 50%), implying that there is indeed instability of the protein in vivo.
The mutation identified in this kindred apparently occurred as a spontaneous mutation in the proband, and was transmitted to two of her four children. RFLP analysis supported the paternity ofthe proband's father. The absolute relationship between the de novo occurrence ofboth the mutation and HS in the proband and transmission of both to two of the children suggests strongly that the mutation is the cause of the clinical disorder and the defective binding ofprotein 4.1 by the mutant 13 spectrin. It is not known at present whether the acanthocytosis is also related to this 13 spectrin defect. Because this mutation was spontaneous, it is not unreasonable that the examination by restriction enzyme digestion ofamplified genomic DNA from the two other HS kindreds affected with a similar disorder on a protein level did not reveal an identical mutation. It is possible that they have mutations nearby that would be missed by restriction digestion with PvuII and MspI.
The majority of patients with HS do not have a defect in ,3 spectrin, but rather have abnormalities leading to deficiency of spectrin and/or ankyrin or band 3. It is currently unclear what proportion of HS cases have a defect in 13 spectrin. However, due to the asymmetric synthetic ratio of a to 1 spectrin, with assembly on the membrane dependent on the 13 chain, one would predict that 1 spectrin mutations would lead to autosomal dominant conditions. For example a point mutation in the COOH-terminal region of 13 spectrin associated with hereditary elliptocytosis (HE) was identifiable in the heterozygous state by ektacytometry and membrane fragmentation ( 18) . In addition, the COOH-terminal truncated 1 spectrin chain variants are clinically affected with HE in the heterozygous state (For review, [ 1] ). Thus, we report the first point mutation in autosomal dominant HS, located in 1 spectrin, and predict that other defects of 1 spectrin will be forthcoming in the future.
